SWAN Isotopen AG is a fully certified modern radiopharmaceutical company situated in the Campus of Inselspital, the University Hospital of Bern. An international team of 35 professionals is producing radiopharmaceuticals for diagnostic and for therapeutic purpose for centers of nuclear medicine in Switzerland.
SWAN Isotopen AG holds marketing authorizations for the most used PET Radiopharmaceuticals used in Oncology and Neurology: FDG (Flu-SWAN), F-Cholin (SWAN-Cholin), F-PSMA (SWAN F-PSMA-1007), Neuraceq© and Formula Magistralis products.
Company Details
- Employees
- 37
- Founded
- -
- Address
- Freiburgstrasse 38, Inselspital,switzerland
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- swantec.ch
- HQ
- Bern
Swan Isotopen Ag Questions
Swan Isotopen Ag's website is swantec.ch
Swan Isotopen Ag's LinkedIn profile is https://ch.linkedin.com/company/swan-isotopen-ag
Swan Isotopen Ag has
37 employees.
View email and phone details for 37
employees at Swan Isotopen Ag.
Swan Isotopen Ag's industry is
Pharmaceutical Manufacturing
Swan Isotopen Ag's top competitors are
Cyclowest,
Insel Gruppe,
Curium Pharma,
Takeda,
Lonza,
Swiss Society Of Industrial Pharmacists (Ssip / Gsia / Sspi),
Iba Radiopharma Solutions,
Special Product's Line - Cdmo Services,
Parsisotope,
Cerbios-Pharma Sa.
Swan Isotopen Ag's categories are Pharmaceutical Manufacturing
Swan Isotopen Ag's founding year is 2007
